Journal of Schizophrenia Disorders And Therapy

Open Access All Content Free

Peer-Reviewed Expert Evaluation

Global International Reach

56+ Research Topics

Scope and Focus

The journal fosters an interdisciplinary approach, covering diverse topics including but not limited to:

Neurobiology and Neuroimaging: Advances in brain structure and function studies related to schizophrenia.
Pharmacology, Genetics, and Neurochemistry: Genetic markers, neurotransmitter systems, and pharmacological interventions.
Neurodevelopmental Aspects: Early-life risk factors and developmental influences on schizophrenia.
Clinical Descriptions and Treatment: Diagnosis, symptomatology, and novel therapeutic approaches.
Behavioral Therapies: Cognitive-behavioral interventions and psychosocial rehabilitation techniques.
Impact on Quality of Life: Social, occupational, and emotional challenges faced by individuals with schizophrenia.
Epidemiology and Public Health Impact: Prevalence, risk factors, and socio-economic burden of schizophrenia.
Comorbidities in Schizophrenia: Co-occurring psychiatric and medical conditions.
Cultural Aspects of Schizophrenia: Cultural influences on perception, treatment, and stigma.
Integrated Treatment Approaches: Multimodal treatment strategies including medication, therapy, and community support.
Mental Health Services and Policy: Accessibility, effectiveness, and innovations in schizophrenia care systems.

AI and Schizophrenia Research

JSDT explores the intersection of AI and schizophrenia, such as the use of artificial intelligence (AI) in diagnosis, treatment, or understanding the underlying mechanisms of the disorder. Contributions from the following research areas are invited but not limited to the following branches:

Adolescent-onset schizophrenia Attention-deficit/hyperactivity disorder Autism spectrum disorder Bipolar disorder Clozapine Cognitive impairment Cognitive Science Cognitive-behavioral therapy Complementary and alternative medicine Deep brain stimulation Delusions Depression Dual diagnosis Electroconvulsive therapy Family therapy First-episode psychosis First-generation antipsychotics Group therapy Hallucinations Herbal remedies Hyperprolactinemia Integrated care Long-term prognosis Major depressive disorder Medication management Mental Health Illiteracy Mental Health Morbidity Negative symptoms Animal-assisted therapy Neurodevelopmental disorders Neuropsychology Obsessive-compulsive disorder Antipsychotic medications Occupational therapy Paranoid type Personality disorders Pharmacogenomics Positive symptoms Post-traumatic stress disorder Prolactin Psychopharmacology Psychosis Anxiety disorders Psychotherapy Psychotic disorders Recovery-oriented services Schizoaffective Disorder Second-generation antipsychotics Social skills training Substance use disorders Suicide tendency Supportive psychotherapy Telepsychiatry Transcranial magnetic stimulation Virtual reality therapy Vocational training